Icon PLC's stock surged 5.95% in after-hours trading on Wednesday, following the release of the company's financial results and an analyst price target increase.
The clinical research organization reported its fourth quarter and full year 2025 results, along with providing the outcome of an audit committee investigation. While specific financial details weren't provided in the news summary, the release of earnings reports typically provides investors with key insights into a company's performance.
Additionally, BofA Global Research raised its price objective on Icon to $105 from $90, representing a significant upward revision that likely contributed to positive investor sentiment. The firm maintained an Underperform rating on the shares despite the increased price target.